Premium
Davis Select US Equity (DUSA)
AMEX
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
WILMINGTON, Mass., Feb. 26 /PRNewswire/ -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that its 2009 corporate highlights and year end financial results press release will be issued...
WILMINGTON, Mass., Feb. 2 PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (NASDAQ:DUSA), a specialty pharmaceutical company focused primarily on the development and marketing of its...
WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and...
Q3 Domestic PDT revenues up 32% year over year; Q3 Non-GAAP loss improves 86% year over year to ($0.2) million WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.®...
WILMINGTON, Mass., Oct. 28 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that global sales...
Second Consecutive Year DUSA Has Been Recognized WILMINGTON, Mass., Oct. 21 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(R) (NASDAQ:DUSA), a specialty pharmaceutical company focused on...
WILMINGTON, Mass., Sept. 2 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA), a dermatology company that is developing and marketing Levulan Photodynamic Therapy (PDT) and...
Q2 Domestic PDT revenues up 24% year over year; Kerastick margins reach a record high of 85% WILMINGTON, Mass., Aug. 11 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA), a...
WILMINGTON, Mass., Aug. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (Nasdaq GM: DUSA) announces that its corporate highlights and second quarter financial results press release will...
Amex to Trade Options on Nine Securities NEW YORK, March 8 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Tuesday, March 9, 2004, on the underlying...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.4 | -0.874316939891 | 45.75 | 45.91 | 44.61 | 43370 | 45.49940655 | SP |
| 4 | 2.95 | 6.95754716981 | 42.4 | 45.91 | 42.007782 | 56804 | 44.52364758 | SP |
| 12 | 1.76 | 4.0376233081 | 43.59 | 45.91 | 41.77 | 46187 | 43.98935059 | SP |
| 26 | 6.53 | 16.8212261721 | 38.82 | 45.91 | 38.08 | 31820 | 43.15052955 | SP |
| 52 | 8.09 | 21.7122920021 | 37.26 | 45.91 | 37.1442 | 29997 | 41.49660552 | SP |
| 156 | 10.77 | 31.1451706189 | 34.58 | 45.91 | 24.67 | 26568 | 34.2449564 | SP |
| 260 | 12.63 | 38.6002444988 | 32.72 | 45.91 | 24.67 | 24408 | 34.35806405 | SP |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
